Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries

Vaccine

Volumn 22, Issue 21-22, 2004, Pages 2791-2799

  Basuni, Ashraf A ^a,b   Butterworth, Lesley ^c   Cooksley, G ^c   Locarnini, S ^d   Carman, W F ^b  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^c Royal Brisbane and Womens Hospital Research Foundation   (Australia)

^d VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

HBsAg mutants; HBV vaccination; Pacific

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ACTIVE IMMUNIZATION; ARTICLE; CONTROLLED STUDY; GENE MUTATION; HEALTH PROGRAM; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFANT; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MOTHER; NEWBORN; POPULATION RESEARCH; PRESSURE; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; STATISTICAL SIGNIFICANCE; VACCINATION;

ADULT; CHILD, PRESCHOOL; DNA, VIRAL; FEMALE; GENE FREQUENCY; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION PROGRAMS; INFANT; INFANT, NEWBORN; MUTATION; PACIFIC ISLANDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TREATMENT FAILURE;

EID: 3142532627     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.01.046     Document Type: Article

References (46)

1. Lee W.M. Hepatitis B virus infection. N. Engl. J. Med. 337:1997;1733-1745
2. Mast E., Alter M.J., Margolis H.S. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine. 17:1999;1730-1733
3. Andre F. Hepatitis B epidemiology in Asia. Vaccine. 18(Suppl 1):2000;S20-S22
4. McMahon B.J., Alward W.L., Hall D.B., Heyward W.L., Bender T.R., Francis D.P., et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J. Infect. Dis. 151:1985;599-603
5. Stevens C.E., Beasley R.P., Tsui J., Lee W.C. Vertical transmission of hepatitis B antigen in Taiwan. N. Engl. J. Med. 292:1975;771-774
6. Hwang L.Y., Roggendorf M., Beasley R.P., Deinhardt F. Perinatal transmission of hepatitis B virus: role of maternal HBeAg and anti-HBc IgM. J. Med. Virol. 15:1985;265-269
7. Chisari F.V. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am. J. Pathol. 156:2000;1117-1132
8. Thomas H.C., Lever A.M.L. Has immunology become important to hepatologists? Prog. Liver Dis. 8:1986;179-189
9. Maynard J.E., Kane M.A., Hadler S.C. Global control of hepatitis B through vaccination: role of hepatitis B vaccine in the expanded programme on immunization. Rev. Infect. Dis. 11(Suppl 3):1989;S574-S578
10. Speed B.R., Dimitrakakis M., Thoma K., Gust I.D. Control of HBV and HDV infection in an isolated Pacific Island: 1. Pattern of infection. J. Med. Virol. 29:1989;13-19
11. Ruff T.A., Gertig D.M., Otto B.F., Gust I.D., Sutanto A., Soewarso T.I., et al. Lombok Hepatitis B Model Immunization Project: toward universal infant hepatitis B immunization in Indonesia. J. Infect. Dis. 171:1995;290-296
12. Oon C.J., Lim G.K., Ye Z., Goh K.T., Tan K.L., Yo S.L., et al. Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine. 13:1995;699-702
13. Chen H.L., Chang M.H., Ni Y.H., Hsu H.Y., Lee P.I., Lee C.Y., et al. Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan. JAMA. 276:1996;906-908
14. Carman W.F., Zanetti A.R., Karayiannis P., Waters J., Manzillo G., Tanzi E., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 336:1990;325-329
15. Okamoto H., Yano K., Nozaki Y., Matsui A., Miyazaki H., Yamamoto K., et al. Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine. Pediatr. Res. 32:1992;264-268
16. Karthigesu V.D., Allison L.M., Fortuin M., Mendy M., Whittle H.C., Howard C.R. A novel hepatitis B virus variant in the sera of immunized children. J. Gen. Virol. 5:1994;443-448
17. Oon C.J., Chen W.N., Shiuan K., Lim G.K. Identification of hepatitis B surface antigen variants with alterations outside the "a" determinant in immunized Singapore infants. J. Infect. Dis. 179:1999;259-263
18. Wilson N., Ruff T.A., Rana B.J., Leydon J., Locarnini S. The effectiveness of the infant hepatitis B immunisation program in Fiji, Kiribati, Tonga and Vanuatu. Vaccine. 18:2000;3059-3066
19. Basuni A.A., Butterworth L.A., Cooksley G., Locarnini S., Carman W.F. An efficient extraction method from blood clots for studies requiring both host and viral DNA. J. Viral. Hepat. 3:2000;241-243
20. Milich D.R., Jones J.E., Hughes J.L., Price J., Raney A.K., McLachlan A. Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc. Natl. Acad. Sci. USA. 87:1990;6599-6603
21. Hsu H.Y., Chang M.H., Chen D.S., Lee C.Y., Sung J.L. Baseline seroepidemiology of hepatitis B virus infection in children in Taipei, 1984: a study just before mass hepatitis B vaccination program in Taiwan. J. Med. Virol. 18:1986;301-307
22. Lee C.Y., Huang L.M., Chang M.H., Hsu C.Y., Wu S.J., Sung J.L., et al. The protective efficacy of recombinant hepatitis B vaccine in newborn infants of hepatitis B e antigen-positive-hepatitis B surface antigen carrier mothers. Pediatr. Infect. Dis. J. 10:1991;299-303
23. Carman W.F., Van Deursen F.J., Mimms L.T., Hardie D., Coppola R., Decker R., et al. The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa. Hepatology. 26:1997;1658-1666
24. Chen W.N., Oon C.J., Toh I. Altered antigenicities of hepatitis B virus surface antigen carrying mutations outside the common "a" determinant. Am. J. Gastroenterol. 95:2000;1098-1099
25. Streefland P.H., Chowdhury A.M., Ramos-Jimenez P. Quality of vaccination services and social demand for vaccinations in Africa and Asia. Bull World Health Organ. 77:1999;722-730
26. Lee S.D., Lo K.J., Wu J.C., Tsai Y.T., Wang J.Y., Ting L.P., et al. Prevention of maternal-infant hepatitis B virus transmission by immunization: the role of serum hepatitis B virus DNA. Hepatology. 6:1986;369-373
27. Ip H.M., Lelie P.N., Wong V.C., Kuhns M.C., Reesink H.W. Prevention of hepatitis B virus carrier state in infants according to maternal serum levels of HBV DNA. Lancet. 1:1989;406-410
28. Alper C.A., Kruskall M.S., Marcus-Bagley D., Craven D.E., Katz A.J., Brink S.J., et al. Genetic prediction of nonresponse to hepatitis B vaccine. N. Engl. J. Med. 321:1989;708-712
29. Diepolder H.M., Jung M.C., Keller E., Schraut W., Gerlach J.T., Gruner N., et al. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B. Clin. Exp. Immunol. 113:1998;244-251
30. Thio C.L., Carrington M., Marti D., O'Brien S.J., Vlahov D., Nelson K.E., et al. Class II HLA alleles and hepatitis B virus persistence in African Americans. J. Infect. Dis. 179:1999;1004-1006
31. McDermott A.B., Cohen S.B., Zuckerman J.N., Madrigal J.A. Human leukocyte antigens influence the immune response to a pre-S/S hepatitis B vaccine. Vaccine. 17:1999;330-339
32. Lee P.I., Chang L.Y., Lee C.Y., Huang L.M., Chang M.H. Detection of hepatitis B surface gene mutation in carrier children with or without immunoprophylaxis at birth. J. Infect. Dis. 176:1997;427-430
33. Hsu H.Y., Chang M.H., Liaw S.H., Ni Y.H., Chen H.L. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology. 30:1999;1312-1317
34. Ngui S.L., O'Connell S., Eglin R.P., Heptonstall J., Teo C.G. Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales. J. Infect. Dis. 176:1997;1360-1365
35. Moriyama K., Nakajima E., Hohjoh H., Asayama R., Okochi K. Immunoselected hepatitis B virus mutant. Lancet. 337:1991;125
36. McMahon G., Ehrlich P.H., Moustafa Z.A., McCarthy L.A., Dottavio D., Tolpin M.D., et al. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology. 15:1992;757-766
37. Hawkins A.E., Gilson R.J., Gilbert N., Wreghitt T.G., Gray J.J., Ahlers-de Boer I., et al. Hepatitis B virus surface mutations associated with infection after liver transplantation. J. Hepatol. 24:1996;8-14
38. Protzer-Knolle U., Naumann U., Bartenschlager R., Berg T., Hopf U., Meyer zum Buschenfelde K.H., et al. Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology. 27:1998;254-263
39. Nainan OV, Stevens CE, Margolis HS. Hepatitis B virus (HBV) antibody resistant mutants among mothers and infants with chronic HBV infection. In: Rizzetto M, Purcell RH, Gerin JL, Verme G, editors. Viral hepatitis and liver disease. Torino: Minerva Medica; 1997. p. 132-4.
40. Roznovsky L., Harrison T.J., Fang Z.L., Ling R., Lochman I., Orsagova I., et al. Unusual hepatitis B surface antigen variation in a child immunised against hepatitis B. J. Med. Virol. 61:2000;11-14
41. Matsumoto T., Nakata K., Hamasaki K., Daikokoku M., Nakao K., Yamashita Y., et al. Efficacy of immunization of high-risk infants against hepatitis B virus evaluated by polymerase chain reaction. J. Med. Virol. 53:1997;255-260
42. He J.W., Lu Q., Zhu Q.R., Duan S.C., Wen Y.M. Mutations in the 'a' determinant of hepatitis B surface antigen among Chinese infants receiving active postexposure hepatitis B immunization. Vaccine. 16:1998;170-173
43. Stroffolini T., Mele A., Tosti M.E., Gallo G., Balocchini E., Ragni P., et al. The impact of the hepatitis B mass immunisation campaign on the incidence and risk factors of acute hepatitis B in Italy. J. Hepatol. 33:2000;980-985
44. del Canho R., Grosheide P.M., Schalm S.W., de Vries R.R., Heijtink R.A. Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates. J. Hepatol. 20:1994;483-486
45. Fortuin M., Karthigesu V., Allison L., Howard C., Hoare S., Mendy M., et al. Breakthrough infections and identification of a viral variant in Gambian children immunized with hepatitis B vaccine. J. Infect. Dis. 169:1994;1374-1376
46. Sehgal A., Gupta I., Sehgal R., Ganguly N.K. Hepatitis B vaccine alone or in combination with anti-HBs immunoglobulin in the perinatal prophylaxis of babies born to HBsAg carrier mothers. Acta Virol. 36:1992;359-366